These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29318637)

  • 1. Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry.
    Worm M; Francuzik W; Renaudin JM; Bilo MB; Cardona V; Scherer Hofmeier K; Köhli A; Bauer A; Christoff G; Cichocka-Jarosz E; Hawranek T; Hourihane JO'; Lange L; Mahler V; Muraro A; Papadopoulos NG; Pföhler C; Poziomkowska-Gęsicka I; Ruëff F; Spindler T; Treudler R; Fernandez-Rivas M; Dölle S
    Allergy; 2018 Jun; 73(6):1322-1330. PubMed ID: 29318637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry.
    Aurich S; Dölle-Bierke S; Francuzik W; Bilo MB; Christoff G; Fernandez-Rivas M; Hawranek T; Pföhler C; Poziomkowska-Gȩsicka I; Renaudin JM; Oppel E; Scherer K; Treudler R; Worm M
    Front Immunol; 2019; 10():750. PubMed ID: 31068925
    [No Abstract]   [Full Text] [Related]  

  • 3. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.
    Gülen T; Hägglund H; Dahlén B; Nilsson G
    Clin Exp Allergy; 2014 Jan; 44(1):121-9. PubMed ID: 24164252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Food-induced anaphylaxis - data from the anaphylaxis registry].
    Worm M; Grünhagen J; Dölle S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Jul; 59(7):836-40. PubMed ID: 27255298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal and Near-Fatal Anaphylaxis: Data From the European Anaphylaxis Registry and National Health Statistics.
    Höfer V; Dölle-Bierke S; Francuzik W; Ruëff F; Sabouraud-Leclerc D; Treudler R; Moeser A; Hartmann K; Pföhler C; Wagner N; Ensina LF; Wedi B; Cardona V; Worm M
    J Allergy Clin Immunol Pract; 2024 Jan; 12(1):96-105.e8. PubMed ID: 37816460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry.
    Kraft M; Knop MP; Renaudin JM; Scherer Hofmeier K; Pföhler C; Bilò MB; Lang R; Treudler R; Wagner N; Spindler T; Hourihane JO; Maris I; Koehli A; Bauer A; Lange L; Müller S; Papadopoulos NG; Wedi B; Moeser A; Ensina LF; Fernandez-Rivas M; Cichocka-Jarosz E; Christoff G; Garcia BE; Poziomkowska-Gęsicka I; Cardona V; Mustakov TB; Rabe U; Mahler V; Grabenhenrich L; Dölle-Bierke S; Worm M;
    Allergy; 2020 Apr; 75(4):901-910. PubMed ID: 31584692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory Anaphylaxis: Data From the European Anaphylaxis Registry.
    Francuzik W; Dölle-Bierke S; Knop M; Scherer Hofmeier K; Cichocka-Jarosz E; García BE; Lang R; Maris I; Renaudin JM; Worm M
    Front Immunol; 2019; 10():2482. PubMed ID: 31749797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology of anaphylaxis].
    Worm M
    Hautarzt; 2013 Feb; 64(2):88-92. PubMed ID: 23344669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.
    Ruëff F; Vos B; Oude Elberink J; Bender A; Chatelain R; Dugas-Breit S; Horny HP; Küchenhoff H; Linhardt A; Mastnik S; Sotlar K; Stretz E; Vollrath R; Przybilla B; Flaig M
    Clin Exp Allergy; 2014; 44(5):736-46. PubMed ID: 24447114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First European data from the network of severe allergic reactions (NORA).
    Worm M; Moneret-Vautrin A; Scherer K; Lang R; Fernandez-Rivas M; Cardona V; Kowalski ML; Jutel M; Poziomkowska-Gesicka I; Papadopoulos NG; Beyer K; Mustakov T; Christoff G; Bilò MB; Muraro A; Hourihane JO; Grabenhenrich LB
    Allergy; 2014 Oct; 69(10):1397-404. PubMed ID: 24989080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylaxis risk factors for hospitalization and intensive care: A comparison between adults and children in an upstate New York emergency department.
    Sundquist BK; Jose J; Pauze D; Pauze D; Wang H; Järvinen KM
    Allergy Asthma Proc; 2019 Jan; 40(1):41-47. PubMed ID: 30582495
    [No Abstract]   [Full Text] [Related]  

  • 12. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
    Brockow K; Jofer C; Behrendt H; Ring J
    Allergy; 2008 Feb; 63(2):226-32. PubMed ID: 18186813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provoking allergens and treatment of anaphylaxis in children and adolescents--data from the anaphylaxis registry of German-speaking countries.
    Hompes S; Köhli A; Nemat K; Scherer K; Lange L; Rueff F; Rietschel E; Reese T; Szepfalusi Z; Schwerk N; Beyer K; Hawranek T; Niggemann B; Worm M
    Pediatr Allergy Immunol; 2011 Sep; 22(6):568-74. PubMed ID: 21435004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry.
    Grabenhenrich LB; Dölle S; Moneret-Vautrin A; Köhli A; Lange L; Spindler T; Ruëff F; Nemat K; Maris I; Roumpedaki E; Scherer K; Ott H; Reese T; Mustakov T; Lang R; Fernandez-Rivas M; Kowalski ML; Bilò MB; Hourihane JO; Papadopoulos NG; Beyer K; Muraro A; Worm M
    J Allergy Clin Immunol; 2016 Apr; 137(4):1128-1137.e1. PubMed ID: 26806049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming.
    Nassiri M; Babina M; Dölle S; Edenharter G; Ruëff F; Worm M
    J Allergy Clin Immunol; 2015 Feb; 135(2):491-9. PubMed ID: 25441633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal Anaphylaxis to Yellow Jacket Stings in Mastocytosis: Options for Identification and Treatment of At-Risk Patients.
    Vos BJPR; van Anrooij B; van Doormaal JJ; Dubois AEJ; Oude Elberink JNG
    J Allergy Clin Immunol Pract; 2017; 5(5):1264-1271. PubMed ID: 28499778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylaxis in Risky Populations.
    Beyaz Ş; Gelincik A
    Curr Pharm Des; 2023; 29(3):224-238. PubMed ID: 36503444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors and Characteristics of Biphasic Anaphylaxis.
    Kraft M; Scherer Hofmeier K; Ruëff F; Pföhler C; Renaudin JM; Bilò MB; Treudler R; Lang R; Cichocka-Jarosz E; Fernandez-Rivas M; Christoff G; Papadopoulos NG; Ensina LF; Hourihane JO; Maris I; Koehli A; García BE; Jappe U; Vogelberg C; Ott H; Lange L; Spindler T; Dölle-Bierke S; Worm M
    J Allergy Clin Immunol Pract; 2020; 8(10):3388-3395.e6. PubMed ID: 32763470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Profile of Patients With Severe Anaphylaxis Hospitalized in the Spanish Hospital System: 1997-2011.
    Nieto-Nieto A; Tejedor-Alonso MA; Farias-Aquino E; Moro-Moro M; Rosado Ingelmo A; Gonzalez-Moreno A; Gil de Miguel A
    J Investig Allergol Clin Immunol; 2017; 27(2):111-126. PubMed ID: 28151396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Induced Anaphylaxis in Latin American Countries.
    Jares EJ; Baena-Cagnani CE; Sánchez-Borges M; Ensina LF; Arias-Cruz A; Gómez M; Cuello MN; Morfin-Maciel BM; De Falco A; Barayazarra S; Bernstein JA; Serrano C; Monsell S; Schuhl J; Cardona-Villa R;
    J Allergy Clin Immunol Pract; 2015; 3(5):780-8. PubMed ID: 26143020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.